Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

USPSTF finalizes recommendation for low-dose CT lung screening

The U.S. Preventive Services Task Force (USPSTF) has given final approval for recommending annual low-dose CT screening for adults age 55-80 at a high risk for lung cancer.

Thumbnail

Formal radiology guidelines for CT lung cancer screening needed

Formalized radiology guidelines for CT screening for lung cancer are needed due to the dearth of uniformity in screening practices reported by US academic medical centers, according to a research letter published online Dec. 9 in JAMA Internal Medicine.

Thumbnail

Percutaneous renal cryoablation safe, successful treatment alternative

Percutaneous renal cryoablation has proven to be a safe and effective alternative technique for patients who cannot undergo surgery and need to preserve their renal function, according to a study published in the December 2013 issue of the American Journal of Roentgenology.

Thumbnail

Bone lesions may be unrelated to a patient’s primary malignancy

Suspicious bone lesions spotted in patients with one known malignancy should not be assumed to represent metastases from the primary malignancy, as some of these lesions will be benign or due to a previously unknown second malignancy, according to a study published in the December issue of the American Journal of Roentgenology.

PET/MR imaging could improve accuracy, patient care over PET/CT

In comparison with same-day PET/CT, PET/MR imaging could allow for more accurate staging of patients with cancer in certain populations, as well as improve patient care, according to a study published in the December 2013 issue of Radiology. 

Overdiagnosis occurring in low-dose CT screening for lung cancer

More than 18 percent of all lung cancers detected with low-dose CT screening (LDCT) are overdiagnosed, according to a study published by JAMA Internal Medicine on Dec. 9. 

RSNA: Dodging common RECIST pitfalls

CHICAGO—Response Evaluation Criteria In Solid Tumors (RECIST) was designed to improve assessment of tumor response to treatment, but extracting RECIST data accurately can present a challenge to those new to the process.

Elekta opens state-of-the-art radiotherapy training center in Beijing

Today, Chinese government officials, key Elekta radiotherapy customers in China and members of Elekta's senior management inaugurated Elekta's Learning and Innovation Center (LINC) in Beijing. The three-story, 1,800sq m (19,375sq ft) education and training facility is equipped with Elekta radiation therapy systems and classrooms to educate oncology and neuroscience professionals as well as Elekta employees on the use of advanced radiotherapy solutions and workflows.

Displaying 641 - 648 of 2554

Around the web

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.